Kamp, Hennicke

Adverse outcome pathways: opportunities, limitations and open questions

Leist, M., Ghallab, A., Graepel, R., Marchan, R., Hassan, R., Bennekou, S. H., Limonciel, A., Vinken, M., Schildknecht, S., Waldmann, T., et al. (2017) · Archives of Toxicology

Animal testing and alternativesAgricultural safety and regulations

Cited by 394

Prediction of liver toxicity and mode of action using metabolomics in vitro in HepG2 cells

Ramirez, T., Strigun, A., Verlohner, A., Huener, H.-A., Peter, E., Herold, M., Bordag, N., Mellert, W., Walk, T., Spitzer, M., et al. (2018) · Archives of Toxicology

Drug-Induced Hepatotoxicity and ProtectionMetabolomics and Mass Spectrometry Studies

Cited by 164

https://www.altex.org/index.php/altex/article/view/1339

Krebs, A., Waldmann, T., Wilks, M. F., van Vugt-Lussenburg, B. M. A., van der Burg, B., Terron, A., Steger-Hartmann, T., Ruegg, J., Rovida, C., Pedersen, E., et al. (2019) · ALTEX

Animal testing and alternativesAgricultural safety and regulations

Cited by 77

Highlight report: Launch of a large integrated European in vitro toxicology project: EU-ToxRisk

Daneshian, M., Kamp, H., Hengstler, J., Leist, M., & van de Water, B. (2016) · Archives of Toxicology

Animal testing and alternativesImmunotoxicology and immune responses

Cited by 65

Analysis of metabolome changes in the bile acid pool in feces and plasma of antibiotic-treated rats

Behr, C., Slopianka, M., Haake, V., Strauss, V., Sperber, S., Kamp, H., Walk, T., Beekmann, K., Rietjens, I. M. C. M., & van Ravenzwaay, B. (2019) · Toxicology and Applied Pharmacology

Gut microbiota and healthDrug Transport and Resistance Mechanisms

Cited by 58